https://www.selleckchem.com/products/gs-4224.html
Alemtuzumab is a humanized monoclonal antibody used as a treatment of multiple sclerosis (MS) and chronic lymphocytic leukemia. It decreases T cell count leading to significant immunosuppression, with increased risk of systemic and ocular infections. Herein, we report a unique case of bilateral acute retinal necrosis (ARN) caused by varicella-zoster virus (VZV) in a patient affected by MS under treatment with alemtuzumab. A 36-year-old man with a relapsing-remitting MS under treatment with alemtuzumab developed bilateral visual loss. An
Like
Comment
Share
